Perspective Therapeutics (CATX) Share-based Compensation (2010 - 2026)

Perspective Therapeutics (CATX) has 17 years of Share-based Compensation data on file, last reported at $2.6 million in Q1 2026.

• For the quarter ending Q1 2026, Share-based Compensation rose 21.69% year-over-year to $2.6 million; the trailing twelve-month figure through Mar 2026 stood at $9.4 million (up 40.67% YoY), and the FY2025 full-year result was $21.3 million, down 10.13% from the prior year.
• Share-based Compensation rose to $2.6 million in Q1 2026, from $2.3 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $2.6 million in Q1 2026 to a low of $125000.0 in Q4 2023.
• A 5-year average of $1.2 million and a median of $982000.0 in 2023 frame the typical range for Share-based Compensation.
• Across the five-year window, Share-based Compensation tumbled 74.8% in 2023 and jumped 1548.0% in 2024, its largest moves.
• Tracing CATX's Share-based Compensation over 5 years: stood at $496000.0 in 2022, then sank by 74.8% to $125000.0 in 2023, then jumped by 1548.0% to $2.1 million in 2024, then advanced by 12.09% to $2.3 million in 2025, then rose by 10.57% to $2.6 million in 2026.
• Business Quant data shows CATX's Share-based Compensation at $2.6 million in Q1 2026, $2.3 million in Q4 2025, and $2.2 million in Q3 2025.